IAMBIGLOBAL BENCHMARK ATLASAtlas WILLIAM PLAYFAIR· LONDON 1786International Aesthetic Medicine
Benchmarking Institute

EXPLORE IAMBI

Explore key pages

Organizations/Medexo

Second Opinion & Treatment Review

Medexo

Independent second opinions and structured review of treatment recommendations.

IAMBI BENCHMARK · 2026

Segment rank16

Second Opinion & Treatment Review

M4 · 34 profiles

PROFILE OVERVIEW

Second Opinion & Treatment Review

Independent second opinions and structured review of treatment recommendations.

Profile notes in the final report
OP-Empfehlung und höchstens sechs Monate alte Unterlagen erforderlich.

Original German excerpt from the IAMBI 2026 final report.

IAMBI BENCHMARK ATLAS · 2026

The result in context.

M4 · Second Opinion & Treatment Review

ASSESSMENT

5.5 / 100

Assessment in the IAMBI Benchmark 2026.

EVIDENCE COVERAGE

11.0 %

Extent of the recorded evidence base.

Study assignment & result source
Profile
O175 · Medexo
Study reference market
Germany
Result
5.5 / 100 · Segment rank 16
Source
IAMBI Benchmark 2026 · Final report · Table 5, row 17

The reference market identifies the assignment within this study. An organization’s international presence is described in its portrait.

Data basis · IAMBI Benchmark 2026

IAMBI Benchmark 2026 scores represent calculated criteria values. The Atlas presents the transmitted results and their associated evidence coverage consistently across profiles, rankings, charts and data exports. The methodology explains criteria, evidence and peer groups.

Methodology & sources